title: Are beta-lactams related to higher morbidity and mortality in urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli?
authors.forename: J H S
authors.initials: JH
authors.lastname: You
authors.forename: H W
authors.initials: HW
authors.lastname: Kei
authors.forename: W C
authors.initials: WC
authors.lastname: Lau
authors.forename: K Y
authors.initials: KY
authors.lastname: Wong
authors.forename: T
authors.initials: T
authors.lastname: Marasinghe
authors.forename: N
authors.initials: N
authors.lastname: Lee
authors.forename: M
authors.initials: M
authors.lastname: Ip
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015780:Carbapenems / Q000494:pharmacology / Q000627:therapeutic use; D004926:Escherichia coli / Q000187:drug effects* / Q000201:enzymology / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D006723:Hong Kong / Q000453:epidemiology; D006801:Humans; D012189:Retrospective Studies; D016896:Treatment Outcome; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D018440:beta-Lactam Resistance; D001618:beta-Lactamases / Q000096:biosynthesis; D047090:beta-Lactams / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D015780:Carbapenems; D047090:beta-Lactams; D001618:beta-Lactamases